Doctors Downplaying Drug’s Suicide Risks Attract FDA’s Scrutiny

  • Drugmaker has proposed changing warning label on suicide risk
  • Physicians receiving Pfizer money reported fewer side effects

The U.S. Food and Drug Administration has a message for doctors: The money you’re taking from pharmaceutical companies may be clouding your judgment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.